AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PRO MEDICUS LTD

118.220

-10.780-8.36%

Volume:1.46M

Turnover:175.22M

Market Cap:12.36B

PE:107.38

High:128.900

Open:126.950

Low:118.220

Close:129.000

52wk High:335.658

52wk Low:118.220

Shares:104.51M

Float Shares:52.96M

Volume Ratio:3.01

T/O Rate:2.75%

Dividend:0.55

Dividend Rate:0.47%

EPS(TTM):1.101

EPS(LYR):1.103

ROE:76.80%

ROA:26.95%

PB:31.77

PE(LYR):107.20

Loading ...

Overview Company News Filings

Pro Medicus (ASX:PME) Net Margin Near 100% Reinforces Bullish Profitability Narratives

Simply Wall St.

BUZZ-Australia's Pro Medicus faces worst week in 14 years on profit miss

Morgans Financial Upgrades Pro Medicus to Buy from Accumulate, Price Target is AU$290

MT Newswires Live

Profit Surge and Expanding Margins Could Be A Game Changer For Pro Medicus (ASX:PME)

Simply Wall St.

BUZZ-Australia's Pro Medicus posts biggest drop in 14 years on profit miss

Stock Track | Pro Medicus Shares Plummet 21.32% Intraday Despite Higher H1 Earnings and Revenue

Pro Medicus Posts H1 Adjusted Pretax Profit AUD90.7 Million

Pro Medicus Posts Higher Fiscal H1 Earnings, Revenue

MT Newswires Live

Pro Medicus Posts Fiscal H1 EPS of AU$1.636, Revenue of AU$128.9 Million Vs FactSet Estimate of AU$128.3 Million

MT Newswires Live

Pro Medicus Ltd H1 Revenue AUD 124.8 Million

THOMSON REUTERS

Pro Medicus Declares Interim Dividend of 32 AU Cents per Share

THOMSON REUTERS

Pro Medicus Ltd H1 Net Income AUD 171.2 Million

THOMSON REUTERS

Pro Medicus Ltd H1 Adjusted Pretax Profit AUD 90.7 Million

THOMSON REUTERS

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

DIARY-Australia, New Zealand corporate earnings week ahead

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

High Growth Tech Stocks To Watch In January 2026

Simply Wall St.

Pro Medicus's New Bull Confident on U.S. Market-Share Gains -- Market Talk

A Look At Pro Medicus’s Valuation As US Hospital Contracts And AI Imaging Draw Attention

Simply Wall St.

Is Pro Medicus (ASX:PME) Using Its US Foothold To Cement a Durable Competitive Edge?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PME.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PME.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","market":"AU","secType":"STK","nameCN":"PRO MEDICUS LTD","latestPrice":118.22,"timestamp":1770959520000,"preClose":129,"halted":0,"volume":1455798,"delay":0,"changeRate":-0.08356589147286822,"nameEN":"PRO MEDICUS LTD","floatShares":52960584,"shares":104510839,"eps":1.101,"marketStatus":"Market Closed","change":-10.78,"latestTime":"02-13 16:12:00 AEDT","open":126.95,"high":128.9,"low":118.22,"amount":175221366,"amplitude":0.082791,"askPrice":119.5,"askSize":100,"bidPrice":118.22,"bidSize":95,"shortable":3,"etf":0,"ttmEps":1.101,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771196400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":129,"dividendRate":0.004652,"openAndCloseTimeList":[[1770937200000,1770958800000]],"volumeRatio":3.005437790036985,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","floatShares":52960584,"roa":"26.95%","roe":"76.80%","lyrEps":1.102806,"volumeRatio":3.005437790036985,"shares":104510839,"dividePrice":0.55,"high":128.9,"amplitude":0.082791,"preClose":129,"low":118.22,"week52Low":118.22,"pbRate":"31.77","psRate":"51.36","week52High":335.658,"institutionHeld":0,"latestPrice":118.22,"committee":-0.025641,"eps":1.101,"divideRate":0.004652,"volume":1455798,"delay":0,"ttmEps":1.101,"open":126.95,"prevYearClose":220.87,"prevWeekClose":157.62,"prevMonthClose":184.12,"prevQuarterClose":220.87,"fiveDayClose":157.62,"twentyDayClose":206.39,"sixtyDayClose":259.36,"dividendPayoutRate":0.4261855666363803,"dividendGrowthYears":6,"dividendGrowthRate":0.34285714285714286,"fiveYearAvgDividendRate":0.0028996530568170345},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PME.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-26","symbol":"PME.AU","amount":0.32,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-02-27","defaultRemindTime":1772060400000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-02-27","currency":"AUD","dateTimestamp":1772024400000,"payDate":"2026-03-20"},{"date":"2026-02-12","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770850800000,"name":null,"time":"","dateTimestamp":1770814800000,"actualEps":null},{"date":"2025-09-03","symbol":"PME.AU","amount":0.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-04","defaultRemindTime":1756857600000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-25","payableDate":"2025-09-04","currency":"AUD","dateTimestamp":1756821600000,"payDate":"2025-09-25"},{"date":"2025-08-14","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755129600000,"name":null,"time":"","dateTimestamp":1755093600000,"actualEps":null},{"date":"2025-02-27","symbol":"PME.AU","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-28","name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-02-28","currency":"AUD","dateTimestamp":1740574800000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PME.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-02","value":0.06,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-19","value":0.07,"currency":"AUD"},{"executeDate":"2021-09-09","recordDate":"2021-09-10","paymentDate":"2021-10-01","value":0.08,"currency":"AUD"},{"executeDate":"2022-03-03","recordDate":"2022-03-04","paymentDate":"2022-03-25","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-08","recordDate":"2022-09-09","paymentDate":"2022-09-30","value":0.12,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PME.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611131372","title":"Pro Medicus (ASX:PME) Net Margin Near 100% Reinforces Bullish Profitability Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2611131372","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611131372?lang=en_us&edition=fundamental","pubTime":"2026-02-13 13:18","pubTimestamp":1770959905,"startTime":"0","endTime":"0","summary":"Pro Medicus (ASX:PME) has just posted its H1 2026 scorecard, headlined by trailing 12 month revenue of A$241.1 million alongside basic EPS of A$2.25, as the company continues to convert its imaging software footprint into solid top and bottom line figures. The company has seen revenue move from A$184.6 million to A$241.1 million across recent trailing 12 month periods, with basic EPS stepping up from A$0.94 to A$2.25 over the same horizon. Reported net profit margin has shifted sharply higher...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/pro-medicus-asxpme-net-margin-near-100-reinforces-bullish-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/pro-medicus-asxpme-net-margin-near-100-reinforces-bullish-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","BK4212","BLSX","BK4112","BLSG","PME.AU"],"gpt_icon":0},{"id":"2611861261","title":"BUZZ-Australia's Pro Medicus faces worst week in 14 years on profit miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2611861261","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611861261?lang=en_us&edition=fundamental","pubTime":"2026-02-13 11:57","pubTimestamp":1770955025,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Pro Medicus faces worst week in 14 years on profit miss** Shares of Australia's Pro Medicus  PME.AX extend losses from the previous session, down 5.8% to A$121.49** Healthcare informatics co on Thursday reported half-year underlying EBITDA of A$93.7 million , 8% below the Visible Alpha consensus estimate; stock fell 23.9% on the day**  Revenue of A$124.8 million also came in 4%-5% below VA consensus, according to Jefferies** Stock set for worst week since late January 2012, down 22.9%** YTD, stock down 45%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL6N3Z907N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0354030511.USD","SG9999018865.SGD","SG9999014914.USD","LU1496350171.SGD","SG9999017495.SGD","LU1064131342.USD","BK4548","LU2506952170.USD","LU0868494617.USD","LU1989773731.SGD","PME.AU","BK4534","LU2506951958.HKD","LU1989772840.SGD","LU0154236417.USD","LU2210149790.SGD","LU1989764748.USD","LU2506951875.HKD","LU0354030438.USD","LU0097036916.USD","LU0823417737.USD","LU1989764664.SGD","LU0985320562.USD","LU2095319765.USD","LU2111349929.HKD","BK4566","LU2265009873.SGD","BK4585","BK4581","LU2271345857.HKD","LU2506952097.USD","LU0823417653.USD","LU0158827781.USD","LU0950375773.USD","LU0345774391.USD","LU1804176565.USD","SG9999014906.USD","LU2028103732.USD","LU2023251221.USD","SG9999014898.SGD","LU1989772923.USD","LU2089283258.USD","LU1633808545.USD","LU1988902786.USD","BK4588","LU2764263203.CNY","SG9999001077.SGD","LU1363072403.SGD","LU2764262908.HKD"],"gpt_icon":1},{"id":"2610794998","title":"Morgans Financial Upgrades Pro Medicus to Buy from Accumulate, Price Target is AU$290","url":"https://stock-news.laohu8.com/highlight/detail?id=2610794998","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610794998?lang=en_us&edition=fundamental","pubTime":"2026-02-12 17:42","pubTimestamp":1770889328,"startTime":"0","endTime":"0","summary":"Morgans Financial Upgrades Pro Medicus to Buy from Accumulate, Price Target is AU$290","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"2610105379","title":"Profit Surge and Expanding Margins Could Be A Game Changer For Pro Medicus (ASX:PME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610105379","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610105379?lang=en_us&edition=fundamental","pubTime":"2026-02-12 12:47","pubTimestamp":1770871655,"startTime":"0","endTime":"0","summary":"Pro Medicus Limited has reported its half-year results to 31 December 2025, with sales rising to A$124.78 million, revenue to A$128.94 million and net income to A$171.22 million, alongside higher basic and diluted earnings per share versus the prior year period.\nThe sharp increase in net income relative to revenue suggests a substantial uplift in profitability, raising questions about the underlying drivers of this margin expansion.\nWith net income now far exceeding the prior year’s level,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/profit-surge-and-expanding-margins-could-be-a-game-changer-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/profit-surge-and-expanding-margins-could-be-a-game-changer-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4212","BK7094","PME","PME.AU"],"gpt_icon":0},{"id":"2610991067","title":"BUZZ-Australia's Pro Medicus posts biggest drop in 14 years on profit miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2610991067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610991067?lang=en_us&edition=fundamental","pubTime":"2026-02-12 11:14","pubTimestamp":1770866046,"startTime":"0","endTime":"0","summary":"BUZZ-Australia'sPro Medicus posts biggest drop in 14 years on profit miss** Shares of Australia's Pro Medicus  PME.AX fall as much as 22.3% to A$131.71, their lowest since August 13, 2024** Stock posts the biggest intraday pct loss since late July 2011** Healthcare informatics co reported half-year net profit after tax of A$171.2 million , up 230.9% on pcp** However, Jefferies says H1 underlying EBITDA of A$93.7 million is 8% below VA consensus** Brokerage adds H1 revenue of A$124.8 million, 4-5% below VA consensus** YTD, stock down 39.9% ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nL6N3Z8070:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"1165770656","title":"Stock Track | Pro Medicus Shares Plummet 21.32% Intraday Despite Higher H1 Earnings and Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1165770656","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165770656?lang=en_us&edition=fundamental","pubTime":"2026-02-12 10:16","pubTimestamp":1770862607,"startTime":"0","endTime":"0","summary":"Pro Medicus Ltd (PME.AU) saw its shares plummet 21.32% during intraday trading on Thursday, hitting their lowest level in nearly two years.The sharp decline came despite the company reporting higher...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PME.AU"],"gpt_icon":0},{"id":"2610995029","title":"Pro Medicus Posts H1 Adjusted Pretax Profit AUD90.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610995029","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610995029?lang=en_us&edition=fundamental","pubTime":"2026-02-12 09:41","pubTimestamp":1770860484,"startTime":"0","endTime":"0","summary":"Feb 12 (Reuters) - Pro Medicus Ltd::*H1 ADJUSTED PRETAX PROFIT AUD 90.7 MILLION*H1 REVENUE AUD 124.8 MILLION*H1 NET INCOME AUD 171.2 MILLION* ((Reuters.Briefs@thomsonreuters.com;))  ((Reuters Investor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nRSD87lRNJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2610967409","title":"Pro Medicus Posts Higher Fiscal H1 Earnings, Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2610967409","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610967409?lang=en_us&edition=fundamental","pubTime":"2026-02-12 07:00","pubTimestamp":1770850848,"startTime":"0","endTime":"0","summary":"Pro Medicus  reported Thursday fiscal first-half earnings of AU$1.636 per share, up from AU$0.4944 a year earlier.Revenue for the six months ended Dec. 31, 2025, was AU$128.9 million, compared with AU$100.8 million a year earlier.The board declared an interim dividend of AU$0.32 per share, up from AU$0.25 a year earlier, payable March 20 to shareholders on record as of Feb. 27.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"2610962242","title":"Pro Medicus Posts Fiscal H1 EPS of AU$1.636, Revenue of AU$128.9 Million Vs FactSet Estimate of AU$128.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610962242","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610962242?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:34","pubTimestamp":1770849290,"startTime":"0","endTime":"0","summary":"Pro Medicus Posts Fiscal H1 EPS of AU$1.636, Revenue of AU$128.9 Million Vs FactSet Estimate of AU$128.3 Million","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2610996446","title":"Pro Medicus Ltd H1 Revenue AUD 124.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610996446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610996446?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:10","pubTimestamp":1770847816,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nPLX438A71:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2610964217","title":"Pro Medicus Declares Interim Dividend of 32 AU Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2610964217","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610964217?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:10","pubTimestamp":1770847816,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nPLX438A71:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"2610644629","title":"Pro Medicus Ltd H1 Net Income AUD 171.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610644629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610644629?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:10","pubTimestamp":1770847816,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nPLX438A71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2610460964","title":"Pro Medicus Ltd H1 Adjusted Pretax Profit AUD 90.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610460964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610460964?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:10","pubTimestamp":1770847806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nPLX62AA58:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"2610721661","title":"Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2610721661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610721661?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:19","pubTimestamp":1770675540,"startTime":"0","endTime":"0","summary":"2219 GMT - Imaging-tech provider Pro Medicus's share price is plumbing 18-month lows after being caught up in the global software selloff. Morgans says investors concerned about AI threats misunderstand what Pro Medicus offers. It upgrades the stock to buy from accumulate. Analyst Iain Wilkie says AI will become one of the most powerful tools in healthcare. But for radiology it still needs stable, high-performance infrastructure to operate. \"Pro Medicus provides that infrastructure, so, in many ways the acceleration toward AI potentially makes its business case more compelling as a product versus peers--at least in the medium term,\" Morgans says. It has a A$290.00/share price target on Pro Medicus, which ended Monday at A$161.17. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2609653957","title":"DIARY-Australia, New Zealand corporate earnings week ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2609653957","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609653957?lang=en_us&edition=fundamental","pubTime":"2026-02-06 09:00","pubTimestamp":1770339600,"startTime":"0","endTime":"0","summary":"DIARY-Australia, New Zealand corporate earnings week aheadFeb 6 (Reuters) - Diary of Australia and New Zealand (.AXJO, .NZ50) corporate earnings for the week ahead AUSTRALIA & NEW ZEALAND EARNINGS Sta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4N3Z11DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7165","JHX","BK7130","NCK.AU","AMP.AU","SGH.AU","BK7007","BK7508","BK7031","GQPIL","BK7006","BK7511","COH.AU","BK7120","WBC.AU","HDN.AU","BK7034","ORG.AU","CIP.AU","BK7501","GQG.AU","BK7162","EVN.AU","BK7095","BK7136","ARF.AU","IAG.AU","TPW.AU","BK7135","AGL.AU","BK7099","PME.AU","NST.AU","BK7119","BK7049","BRG.AU","CBA.AU","BK4135","CLW.AU","BK7005","CSL.AU","BK7062","BK7112","BK7506","BK7507","BK7107","S32.AU","BK7094","BK4011"],"gpt_icon":0},{"id":"2607050531","title":"Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2607050531","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607050531?lang=en_us&edition=fundamental","pubTime":"2026-01-30 07:47","pubTimestamp":1769730420,"startTime":"0","endTime":"0","summary":"2347 GMT - Imaging-tech provider Pro Medicus has underperformed Australia's benchmark S&P/ASX 200 index so far this year. For investors, that offers an attractive setup ahead of its 1H result next month, MS says. It points to record contract implementations by Pro Medicus and stable demand. At the same time, estimates are conservative and AI concerns are overstated, analyst Chris Boulus says. MS forecasts 1H revenue growth of 36% on year and an Ebitda margin of 77%. MS retains an overweight call and A$350.00/share price target on Pro Medicus, which is down 0.4% at A$181.00. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2607288227","title":"High Growth Tech Stocks To Watch In January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2607288227","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607288227?lang=en_us&edition=fundamental","pubTime":"2026-01-29 03:05","pubTimestamp":1769627154,"startTime":"0","endTime":"0","summary":"As Australian shares continue their upward trajectory, buoyed by a rally in the S&P 500 and anticipation surrounding upcoming inflation data, investors are closely watching how these factors might influence future Reserve Bank of Australia rate decisions. In this dynamic environment, high growth tech stocks can be particularly appealing for their potential to capitalize on market optimism and technological advancements, making them worthy of attention as we enter January 2026.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/high-growth-tech-stocks-to-watch-in-january-2026-7","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/high-growth-tech-stocks-to-watch-in-january-2026-7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","XJO.AU","BK7094","RUL.AU","BK7016","PME.AU","NXL.AU","XAO.AU"],"gpt_icon":0},{"id":"2606227076","title":"Pro Medicus's New Bull Confident on U.S. Market-Share Gains -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2606227076","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606227076?lang=en_us&edition=fundamental","pubTime":"2026-01-27 08:27","pubTimestamp":1769473620,"startTime":"0","endTime":"0","summary":"0027 GMT - Australian imaging-tech provider Pro Medicus's solid start to FY 2026 contributes to Macquarie upgrading the stock to outperform, from neutral. Macquarie says it now has increased confidence in Pro Medicus's ability to expand its share of the U.S. market. \"We see recent softness in the share price as transient,\" Macquarie says. \"The implementation of AI tools will strengthen Pro Medicus's offering, while new contracts in FY 2026 supports growth across all customer types.\" Pro Medicus is up 1.8% at A$184.11. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PME.AU","BK7094"],"gpt_icon":0},{"id":"2605287393","title":"A Look At Pro Medicus’s Valuation As US Hospital Contracts And AI Imaging Draw Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2605287393","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605287393?lang=en_us&edition=fundamental","pubTime":"2026-01-24 05:37","pubTimestamp":1769204266,"startTime":"0","endTime":"0","summary":"Why Pro Medicus is back in focus\nRecent media coverage around Pro Medicus (ASX:PME) has zeroed in on its premium radiology imaging software, long term US hospital contracts, and use of AI, while investor attention is also focused on its premium pricing.\nSee our latest analysis for Pro Medicus.\nDespite the recent excitement around its US contracts and AI capabilities, Pro Medicus has been in a technical downtrend, with a 30 day share price return of a 19.83% decline and a 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/a-look-at-pro-medicuss-valuation-as-us-hospital-contracts-an","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/a-look-at-pro-medicuss-valuation-as-us-hospital-contracts-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ROE","BK7094","PME.AU"],"gpt_icon":0},{"id":"2605981874","title":"Is Pro Medicus (ASX:PME) Using Its US Foothold To Cement a Durable Competitive Edge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2605981874","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605981874?lang=en_us&edition=fundamental","pubTime":"2026-01-22 16:41","pubTimestamp":1769071317,"startTime":"0","endTime":"0","summary":"In recent months, Pro Medicus has drawn heightened attention as a premium health-tech provider, with its radiology imaging software underpinning long-term contracts at major US hospitals and clinics. \nAn important angle for investors is how Pro Medicus’ advanced imaging and AI capabilities have helped it compete against much larger legacy vendors in a highly specialised market. \nWe’ll now examine how this growing US hospital footprint and premium positioning shape Pro Medicus’ broader...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/is-pro-medicus-asxpme-using-its-us-foothold-to-cement-a-dura","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/is-pro-medicus-asxpme-using-its-us-foothold-to-cement-a-dura","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4212","BK4528","AI","BK7094","BK4587","BK4551","BK4588","PME.AU","BK4023","PME","BK4585","BK4543"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":89,"code":"91000000","status":"200"}]}}